Medical and Pharmaceutical South Korean research institution develops lung cancer breath test with 95% accuracy It uses a machine with 70 sensors to detect volatile organic compounds associated with the disease Rowan DunneMarch 25, 2025
Medical and Pharmaceutical Ireland launches largest lung cancer research program to date This €4.9-million-euro initiative is being funded by the Irish Cancer Society Rowan DunneOctober 30, 2024
Medical and Pharmaceutical bioAffinity Technologies makes phlegm lung cancer test widely available to Veterans The University of California says 15 veterans die from lung cancer around the world every day Rowan DunneOctober 9, 2024
Health & Wellness World Lung Day highlights need for improved lung cancer screening rates Combatting air pollution and quitting smoking are also key themes Rowan DunneSeptember 25, 2024
Medical and Pharmaceutical Malaysia leads way in fight against lung diseases at World Cancer Congress The nation introduced a proposal to the WHO for global prioritization of lung health Rowan DunneSeptember 24, 2024
Medical and Pharmaceutical UK researchers conduct successful trials with saliva ‘dip’ lung cancer test Their findings have been published in the Royal Society of Chemistry's Analyst journal Rowan DunneSeptember 20, 2024
Medical and Pharmaceutical New Brunswick to use blood testing method for identifying lung cancer This will be the first time that labs in Atlantic Canada utilize liquid biopsies to test for the disease Rowan DunneSeptember 16, 2024
Medical and Pharmaceutical Prelude Therapeutics Incorporated shares drop 30% on clinical trial news The drug in question is also presently being tested in an ongoing dose-escalation Phase 1 trial for patients with solid tumours Joseph MortonSeptember 13, 2024
AI and Autonomy AI capable of identifying lung cancer years before symptoms manifest Qure.ai just showcased the capabilities of its AI-powered chest X-ray at the World Conference on Lung Cancer Rowan DunneSeptember 11, 2024
Medical and Pharmaceutical AstraZeneca shares slide on disappointing lung cancer drug trial results "Dato-DXd" was thought to have immense potential but now appears to be a disappointment Rowan DunneSeptember 10, 2024